Pharmaceutical / Drug Definition :
Enhances water reabsorption by increasing permeability of renal collecting ducts to adenosine monophosphate and water, thereby reducing urinary output and increasing urine osmolality. Also increases factor VIII (antihemophilic factor) activity.
In the United States, Desmopressin Acetate is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Desmopressin Acetate.
FDA Label Requirements and Exceptions
FDA Import Information
Desmopressin Acetate (Desmopressin Acetate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Desmopressin Acetate (Desmopressin Acetate Suppliers)
- Processors Desmopressin Acetate
- Repackers Desmopressin Acetate
- Relabelers Desmopressin Acetate
- Exporters Desmopressin Acetate
- Importers Desmopressin Acetate
For more information about Desmopressin Acetate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.